Valuation: EXACT Therapeutics

Market Cap 46.81M 4.93M 4.26M 3.98M 3.65M 6.87M 469M 6.98M 46.72M 18.34M 235M 18.51M 18.1M 777M P/E 2024
-2.49x
P/E 2025 -1x
Enterprise Value 22.9M 2.41M 2.09M 1.95M 1.79M 3.36M 230M 3.41M 22.85M 8.97M 115M 9.06M 8.86M 380M EV / Sales 2024
-
EV / Sales 2025 1,074,437,000x
Free-Float
30.97%
Yield 2024 *
-
Yield 2025 -
1 day+1.35%
1 week+7.14%
Current month+7.14%
1 month+4.90%
3 months-47.92%
6 months-60.11%
Current year-45.65%
1 week 0.68
Extreme 0.675
0.8
1 month 0.64
Extreme 0.635
0.8
Current year 0.58
Extreme 0.58
2.7
1 year 0.58
Extreme 0.58
2.98
3 years 0.58
Extreme 0.58
20
5 years 0.58
Extreme 0.58
24
10 years 0.58
Extreme 0.58
53.59
Manager TitleAgeSince
Chief Executive Officer 66 2022-06-05
Chief Operating Officer - 2011-12-31
Director of Finance/CFO - 2022-09-30
Director TitleAgeSince
Chairman 55 2018-06-21
Chairman - 2022-06-07
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap.
1/4/23 Buy

Chairman

2,500 0.0083%
1/4/23 Buy

Founder

2,500 0.0083%
1/4/23 Buy

Chief Financial Officer

2,500 0.0083%
Change 5-day change 1-year change 3-year change Capi.($)
+1.35%+7.14%-70.00%-93.24% 4.9M
+0.99%+1.78%+4.07%+16.73% 48.7B
+0.97%+5.78%+467.60%+569.28% 42.05B
+1.46%+0.31%+31.74%+7.50% 38.26B
+4.74%+9.40%+15.90%+84.36% 37.5B
+2.21%+4.89%+17.24%+51.64% 31.44B
+1.79%+4.30% - - 16.47B
-0.33%+1.26%+36.29%+124.42% 16.33B
-0.11%+2.41%+6.24%+18.87% 13.98B
-1.46%+12.83%+75.14%+27.79% 12.68B
Average +1.18%+3.80%+64.91%+89.71% 25.74B
Weighted average by Cap. +1.57%+2.31%+98.97%+134.79%

Financials

2024 2025
Net sales - 0.06 0.01 0.01 0.01 0 0.01 0.59 0.01 0.06 0.02 0.3 0.02 0.02 0.98
Net income -52.33M -5.51M -4.77M -4.45M -4.08M -7.68M -524M -7.8M -52.22M -20.5M -263M -20.69M -20.24M -869M -86.97M -9.16M -7.92M -7.4M -6.79M -12.76M -871M -12.97M -86.78M -34.06M -437M -34.39M -33.63M -1.44B
Net Debt -98.89M -10.41M -9.01M -8.41M -7.72M -14.51M -991M -14.74M -98.68M -38.73M -497M -39.1M -38.24M -1.64B -23.91M -2.52M -2.18M -2.03M -1.87M -3.51M -240M -3.56M -23.86M -9.37M -120M -9.45M -9.25M -397M
Logo EXACT Therapeutics
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The Company's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. It is done through harnessing the power of ultrasound in combination with ACT formulation.
Employees
11
Date Price Change Volume
26-08-07 NOK 0.7500 +1.35% 5,200
26-08-06 NOK 0.7400 +8.82% 12,381
26-08-05 NOK 0.6800 -15.00% 54,312
26-08-04 NOK 0.8000 0.00% 0
26-08-03 NOK 0.8000 +14.29% 30,250
  1. Stock Market
  2. Stocks
  3. EXTX Stock